China Shineway Pharmaceutical Group Limited (HK:2877) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Shineway Pharmaceutical Group reported a 16.9% decline in turnover to RMB 2,887 million for the nine months ending September 2024. The decrease is attributed to significant drops in sales of injection and soft capsule products, while turnover for products in other forms saw a slight increase. Investors are advised to be cautious when dealing with the company’s shares.
For further insights into HK:2877 stock, check out TipRanks’ Stock Analysis page.